Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05007899 · ClinicalTrials.gov registry record · Phase 4
Alternate Day Versus Daily Oral Iron Therapy in Adolescents
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT05007899 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 13 participants.
The verdict
NCT05007899, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
Iron deficiency anemia affects over half of girls and young women with heavy periods and is the most common cause of anemia worldwide. Most girls with heavy periods who also have iron deficiency anemia are prescribed iron to take by mouth every day by their doctor. There are some studies showing that taking iron every other day may actually help the iron be absorbed into the bloodstream better. This study is trying to compare how taking iron every other day compares to taking iron daily for treatment of anemia. The goal of this clinical research study is to learn which of the two methods of care will be the best way for girls and young women with iron deficiency anemia to take iron supplementation.
Interventions
- DRUG Ferrous sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2022-12-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05007899
The ClinicalTrials.gov registry entry for NCT05007899 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferrous sulfate is the first listed.
NCT05007899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05007899 about?
NCT05007899 is a clinical study titled "Alternate Day Versus Daily Oral Iron Therapy in Adolescents". Iron deficiency anemia affects over half of girls and young women with heavy periods and is the most common cause of anemia worldwide. Most girls with heavy periods who also have iron deficiency anemia are prescribed iron to take by mouth every day by their doctor. There are some studies showing tha...
What is the current status of trial NCT05007899?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2020-12-21. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT05007899?
The interventions under investigation include: Ferrous sulfate (DRUG).
Who is sponsoring clinical trial NCT05007899?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.